Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

KALA BIO, Inc. Director's Dealing 2026

Feb 9, 2026

35091_dirs_2026-02-09_89d57861-5443-4320-a09d-028d6e9a6286.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: KALA BIO, Inc. (KALA)
CIK: 0001479419
Period of Report: 2026-01-30

Reporting Person: Berger Chaim D. (Director)